CYBRD1 and ovarian carcinoma: Chen et al. have the opinion that cytochrome b reductase 1 (CYBRD1) is highly expressed in ovarian cancer and mediates the occurrence and development of ovarian cancer by affecting iron uptake and ferroptosis‐related signaling pathways [135].